Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.64 USD -2.94% Market Closed
Market Cap: 777.9m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcellera Biologics Inc
Capital Expenditures Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Capital Expenditures
-$77.5m
CAGR 3-Years
-74%
CAGR 5-Years
-71%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Capital Expenditures
-CA$58.6k
CAGR 3-Years
-10%
CAGR 5-Years
-139%
CAGR 10-Years
-19%

See Also

What is Abcellera Biologics Inc's Capital Expenditures?
Capital Expenditures
-77.5m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Capital Expenditures amounts to -77.5m USD.

What is Abcellera Biologics Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-71%

Over the last year, the Capital Expenditures growth was -7%. The average annual Capital Expenditures growth rates for Abcellera Biologics Inc have been -74% over the past three years , -71% over the past five years .

Back to Top